VEGFA and neoplasm: Studies have reported that endothelial cells could show anti-coagulation events, vascular co-option of normal vasculature, evasive resistance to vascular endothelial growth factor (VEGF) pathway inhibitors, vascular remodeling, and intrinsic tolerance due to changes in tumor micro-environment that ultimately disrupts the anti-angiogenic effect of MC.